Aspergilloma

Revision as of 14:24, 25 September 2012 by Charmaine Patel (talk | contribs)
Jump to navigation Jump to search

Aspergilloma Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Aspergilloma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Aspergilloma On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Aspergilloma

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Aspergilloma

CDC on Aspergilloma

Aspergilloma in the news

Blogs on Aspergilloma

Directions to Hospitals Treating Aspergilloma

Risk calculators and risk factors for Aspergilloma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Etiology

The most common place affected by aspergillomas is the lung. Aspergillus fumigatus, the most common species, is typically inhaled as small (2 to 3 micrometer) spores which do not affect people without underlying lung or immune system disease. However, people who have pre-existing lung problems, especially the cavities typically caused by tuberculosis, are at risk for developing aspergillomas. The fungus settles in a cavity and is able to grow free from interference because the immune system is unable to penetrate into the cavity. As the fungus multiplies, it forms a ball which incorporates dead tissue from the surrounding lung, mucus, and other debris.

Clinical syndrome

Typically, individuals who are affected by aspergillomas do not have symptoms related to the infestation. People often co-exist for decades with aspergillomas prior to incidental diagnosis, typically by x-ray or computed tomography. However, a small percentage of aspergillomas invade into the wall of the cavity and can result in bleeding. Thus, the most common symptom of aspergillomas is coughing up blood (hemoptysis). Although this can occasionally be life-threatening, the amount of blood produced is usually inconsequential.

Aspergillomas can form in other body cavities. Aspergillus can form abscesses in the brain, usually in people who are immunocompromised. They can also form within the different sinuses in the face, within the kidneys and urinary system, the ear canal, and on the heart valves.

Diagnosis

The imaging findings are

  • Intracavitary mass
  • Usually in upper lobes
  • Air may surround aspergilloma (Monod sign). This is not to be confused with the Air crescent sign seen with invasive apergillosis
  • Moves with changing positions
  • Adjacent pleural thickening is common

Treatment

Most cases of aspergilloma do not require treatment. Treatment of diseases which increase the risk of aspergilloma, such as tuberculosis, may help prevent their formation. In cases complicated by severe hemoptysis, surgery may be required to remove the aspergilloma and stop the bleeding. There has been interest in treatment with anti-fungal medications such as itraconazole, but as of 2005, none has been shown to eradicate aspergillomas.

References

  • Soubani AO, Chandrasekar PH. The clinical spectrum of pulmonary aspergillosis. Chest. 2002 Jun;121(6):1988-99. Review. PMID 12065367


nl:Aspergilloom de:Aspergillom


Template:WS Template:Jb1